Revenue: As of FY2025, the actual value is USD 7.009 M.

EPS: As of FY2025, the actual value is USD -11.16.

EBIT: As of FY2025, the actual value is USD -269.32 M.

Sharps Technology, Inc. reported a consolidated net loss of - $282.5 million for the year ended December 31, 2025, which is significantly wider than the - $9.3 million net loss in 2024. The company’s accumulated deficit reached - $316.9 million as of December 31, 2025.

Medical Device Packaging Segment (Continuing Operations)

• Net Revenue: The segment recognized $204,120 in revenue for 2025, compared to $0 in 2024.
• Cost of Goods Sold: Total cost of goods sold was $617,445 in 2025, including a $418,869 inventory reserve, with no cost of goods sold in 2024.
• Gross Margin (Loss): A gross loss of - $413,325 was reported in 2025, versus $0 in 2024.
• Research and Development Expenses: R&D expenses decreased to $198,762 in 2025 from $531,233 in 2024.
• Selling, General and Administrative Expenses: These expenses were $132,539 in 2025, down from $472,604 in 2024.
• Loss from Operations: The segment’s operating loss was - $744,626 in 2025, an improvement from - $1,003,837 in 2024.

Digital Assets Segment

• Staking Revenue, Net: The segment generated $6,805,009 in net staking revenue in 2025, with no activity in 2024.
• Warrant Issuance – Related Party: Expenses totaled $101,331,513 in 2025.
• Consulting Fees – Related Parties: Fees amounted to $3,433,333 in 2025.
• Selling, General and Administrative Expenses: These were $1,079,853 in 2025.
• Unrealized Loss on Digital Assets: An unrealized loss of $152,952,163 was recognized in 2025, primarily due to a decrease in the market value of SOL.
• Realized Loss on Digital Assets: A realized loss of $1,286,284 was recorded in 2025.
• Digital Asset Transaction Expenses: Expenses were $872,934 in 2025.
• Realized Loss on Derivatives: The segment incurred a realized loss of - $4,986,500 on derivatives in 2025.
• Loss from Operations: The segment reported a loss from operations of - $254,151,072 in 2025.

Corporate (Non-Segment)

• Selling, General and Administrative Expenses: These expenses increased to $14,839,676 in 2025 from $4,563,763 in 2024, partly due to increased staffing for the Digital Asset Treasury and higher public company expenses.
• Interest Expense, Net: Net interest expense was - $396,105 in 2025, an improvement from - $1,664,712 in 2024 due to higher cash balances and debt repayment.
• Fair Market Value Adjustment on Warrants: The company recorded a gain of $4,803,098 in 2025, compared to $3,016,936 in 2024.
• Other Expense: No other expense was recorded in 2025, compared to - $1,009,891 in 2024.

Discontinued Operations (Safegard Medical Kft)

• Net Loss from Discontinued Operations: The loss from discontinued operations was - $12,166,690 in 2025, including a - $1,078,348 loss on disposal, compared to - $4,070,935 in 2024.

Consolidated Cash Flows

• Net Cash Used in Operating Activities: Sharps Technology, Inc. used - $10,990,651 in operating activities in 2025, an increase from - $4,401,392 in 2024, mainly due to digital asset transaction fees and higher G&A expenses, partially offset by lower R&D.
• Net Cash Used in Investing Activities: Investing activities used - $187,522,741 in 2025, primarily for the purchase of digital assets ($170,519,290) and stablecoin ($17,003,451), compared to - $1,000,000 used in 2024.
• Net Cash Provided by Financing Activities: Financing activities provided $215,509,778 in 2025, largely from offerings and warrant exercises, including $212,102,902 in net proceeds from the August PIPE and ATM Sales Agreement, significantly higher than the $5,907,407 provided in 2024.

Liquidity and Capital Resources

• As of December 31, 2025, Sharps Technology, Inc. had a cash balance of $10,382,744 and working capital of $14,187,484.
• The company held $250,111,125 in digital assets at fair value as of December 31, 2025, with a large portion unlocked and readily available for sale.

Outlook / Guidance

Sharps Technology, Inc. intends to maintain sufficient cash and other immediately liquid resources to satisfy current obligations. The company plans to prioritize long-term growth, potentially using proceeds from the sale of SOL to fund expansion plans. Additionally, it may explore allocating a portion of its treasury to stablecoin-denominated lending or other yield-generating activities as regulatory frameworks mature.